35/120
1.5 / 5 stars
All 120 Win/Lose results shown below
MCK Roast Me summary
MCKESSON CORP (MCK). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Win.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Win.
Trailing 1 year (4 quarters): 6 wins, 6 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseMCK / S&P MCK unavailable / 15.20% |
LoseMCK / S&P 8.84% / 15.00% |
LoseMCK / S&P 49.30% / 50.40% |
| 2026-Q12/3 |
LoseMCK / S&P MCK unavailable / -4.33% |
WinMCK / S&P 12.36% / 11.30% |
WinMCK / S&P 49.22% / 27.70% |
| 2025-Q42/3 |
LoseMCK / S&P MCK unavailable / 2.65% |
WinMCK / S&P 15.49% / 9.00% |
WinMCK / S&P 58.94% / 13.40% |
| 2025-Q32/3 |
LoseMCK / S&P MCK unavailable / 8.12% |
WinMCK / S&P 17.23% / 4.61% |
WinMCK / S&P 66.10% / 13.45% |
| 2025-Q22/3 |
LoseMCK / S&P MCK unavailable / 10.94% |
WinMCK / S&P 20.35% / 4.83% |
WinMCK / S&P 11.86% / 10.63% |
| 2025-Q12/3 |
LoseMCK / S&P MCK unavailable / -4.27% |
WinMCK / S&P 16.22% / 4.98% |
WinMCK / S&P 14.87% / 10.57% |
| 2024-Q41/3 |
LoseMCK / S&P MCK unavailable / 2.41% |
WinMCK / S&P 14.29% / 5.25% |
LoseMCK / S&P -1.22% / 6.15% |
| 2024-Q31/3 |
LoseMCK / S&P MCK unavailable / 5.89% |
WinMCK / S&P 13.43% / 5.89% |
LoseMCK / S&P -23.85% / 6.11% |
| 2024-Q21/3 |
LoseMCK / S&P MCK unavailable / 4.28% |
WinMCK / S&P 10.46% / 5.38% |
LoseMCK / S&P -16.73% / 5.12% |
| 2024-Q11/3 |
LoseMCK / S&P MCK unavailable / 10.56% |
WinMCK / S&P 11.65% / 5.71% |
LoseMCK / S&P -10.55% / 5.59% |
| 2023-Q41/3 |
LoseMCK / S&P MCK unavailable / 11.69% |
WinMCK / S&P 10.08% / 6.81% |
LoseMCK / S&P 1.42% / 7.78% |
| 2023-Q31/3 |
LoseMCK / S&P MCK unavailable / -3.27% |
LoseMCK / S&P 7.01% / 7.52% |
WinMCK / S&P 79.90% / -5.03% |
| 2023-Q21/3 |
LoseMCK / S&P MCK unavailable / 8.74% |
LoseMCK / S&P 5.81% / 9.50% |
WinMCK / S&P 186.34% / -8.57% |
| 2023-Q11/3 |
LoseMCK / S&P MCK unavailable / 7.50% |
LoseMCK / S&P 4.83% / 10.77% |
WinMCK / S&P 246.20% / -15.69% |
| 2022-Q41/3 |
LoseMCK / S&P MCK unavailable / 7.56% |
LoseMCK / S&P 6.57% / 11.88% |
WinMCK / S&P 148.35% / -17.99% |
| 2022-Q30/3 |
LoseMCK / S&P MCK unavailable / -4.88% |
LoseMCK / S&P 8.38% / 13.47% |
LoseMCK / S&P MCK unavailable / -1.41% |
| 2022-Q20/3 |
LoseMCK / S&P MCK unavailable / -16.10% |
LoseMCK / S&P 9.47% / 13.71% |
LoseMCK / S&P MCK unavailable / 11.04% |
| 2022-Q10/3 |
LoseMCK / S&P MCK unavailable / -4.60% |
LoseMCK / S&P 10.80% / 15.97% |
LoseMCK / S&P MCK unavailable / 42.23% |
| 2021-Q40/3 |
LoseMCK / S&P MCK unavailable / 11.03% |
LoseMCK / S&P 8.16% / 15.00% |
LoseMCK / S&P MCK unavailable / 96.40% |
| 2021-Q30/3 |
LoseMCK / S&P MCK unavailable / 0.58% |
LoseMCK / S&P 7.17% / 10.77% |
LoseMCK / S&P -334.26% / 69.42% |
| 2021-Q20/3 |
LoseMCK / S&P MCK unavailable / 8.55% |
LoseMCK / S&P 6.16% / 6.58% |
LoseMCK / S&P -628.68% / 51.81% |
| 2021-Q11/3 |
LoseMCK / S&P MCK unavailable / 6.17% |
WinMCK / S&P 3.11% / -1.06% |
LoseMCK / S&P -670.91% / 7.39% |
| 2020-Q41/3 |
LoseMCK / S&P MCK unavailable / 12.15% |
WinMCK / S&P 5.64% / -3.72% |
LoseMCK / S&P MCK unavailable / -33.42% |
| 2020-Q31/3 |
LoseMCK / S&P MCK unavailable / 8.93% |
WinMCK / S&P 5.50% / -2.04% |
LoseMCK / S&P MCK unavailable / -27.10% |
| 2020-Q22/3 |
LoseMCK / S&P MCK unavailable / 20.54% |
WinMCK / S&P 6.24% / -0.46% |
WinMCK / S&P 71.02% / -27.11% |
| 2020-Q12/3 |
LoseMCK / S&P MCK unavailable / -19.60% |
WinMCK / S&P 7.81% / 3.47% |
WinMCK / S&P 2811.76% / -14.75% |
| 2019-Q40/3 |
LoseMCK / S&P MCK unavailable / 9.07% |
LoseMCK / S&P 5.35% / 5.36% |
LoseMCK / S&P MCK unavailable / 2.99% |
| 2019-Q31/3 |
LoseMCK / S&P MCK unavailable / 1.70% |
WinMCK / S&P 5.24% / 5.02% |
LoseMCK / S&P -566.67% / 0.21% |
| 2019-Q20/3 |
LoseMCK / S&P MCK unavailable / 4.30% |
LoseMCK / S&P 3.59% / 6.64% |
LoseMCK / S&P MCK unavailable / 8.65% |
| 2019-Q10/3 |
LoseMCK / S&P MCK unavailable / 13.65% |
LoseMCK / S&P 2.86% / 8.12% |
LoseMCK / S&P -46.88% / 14.29% |
| 2018-Q40/3 |
LoseMCK / S&P MCK unavailable / -13.52% |
LoseMCK / S&P 3.93% / 9.05% |
LoseMCK / S&P -105.51% / 18.23% |
| 2018-Q30/3 |
LoseMCK / S&P MCK unavailable / 7.71% |
LoseMCK / S&P 4.44% / 10.21% |
LoseMCK / S&P -96.48% / 19.06% |
| 2018-Q20/3 |
LoseMCK / S&P MCK unavailable / 3.43% |
LoseMCK / S&P 5.03% / 9.03% |
LoseMCK / S&P -108.16% / 14.46% |
| 2018-Q10/3 |
LoseMCK / S&P MCK unavailable / -0.76% |
LoseMCK / S&P 4.95% / 7.68% |
LoseMCK / S&P -98.59% / 12.46% |
| 2017-Q41/3 |
LoseMCK / S&P MCK unavailable / 6.64% |
LoseMCK / S&P 4.55% / 7.03% |
WinMCK / S&P 159.57% / 13.82% |
| 2017-Q31/3 |
LoseMCK / S&P MCK unavailable / 4.48% |
LoseMCK / S&P 3.96% / 5.68% |
WinMCK / S&P 145.56% / 17.57% |
| 2017-Q21/3 |
LoseMCK / S&P MCK unavailable / 3.09% |
LoseMCK / S&P 3.51% / 4.83% |
WinMCK / S&P 126.48% / 17.74% |
| 2017-Q12/3 |
LoseMCK / S&P MCK unavailable / 6.07% |
WinMCK / S&P 4.01% / 3.67% |
WinMCK / S&P 134.33% / 13.32% |
| 2016-Q41/3 |
LoseMCK / S&P MCK unavailable / 3.82% |
WinMCK / S&P 3.90% / 2.09% |
LoseMCK / S&P 1.20% / 7.05% |
| 2016-Q32/3 |
LoseMCK / S&P MCK unavailable / 3.85% |
WinMCK / S&P 3.49% / 0.20% |
WinMCK / S&P 9.31% / -3.15% |
Dividend-reinvested, split-adjusted total return
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |